ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.138,87
0,81%
S&P 500
5.159,06
0,61%
Dow Jones
38.818,48
0,37%
Euro vs US Dollar
1,07865
0,27%
Bitcoin
64.099,43
0,16%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. GSK plc (GSK)

  7. GSK plc (GSK) News

GSK

GSK (GSK)

GSK plc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:GSK
DatumZeitQuelleÜberschriftSymbolFirma
26/04/202413h48IH Market NewsAnglo American Rejects BHP Group’s Offer, Toyota Invests $1.4 Billion in Indiana, and More NewsNYSE:GSKGSK plc
16/03/202413h00Business WirePositive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancerNYSE:GSKGSK plc
08/03/202418h48Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
07/03/202418h00Business WireGSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising RiseNYSE:GSKGSK plc
07/03/202412h13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
06/03/202417h11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
05/03/202419h09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
05/03/202418h30Edgar (US Regulatory)Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).NYSE:GSKGSK plc
05/03/202418h10Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NYSE:GSKGSK plc
05/03/202412h10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
01/03/202416h29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
01/03/202415h55Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
29/02/202412h27Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
29/02/202412h27Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
29/02/202412h11IH Market NewsShares of WW International Plummet after Oprah Exits, EA Announces Workforce Reduction and Restructuring Plan, and Latest NewsNYSE:GSKGSK plc
26/02/202416h38Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
26/02/202412h39Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
22/02/202416h45Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
15/02/202412h34IH Market NewsCisco Systems Stock Drops 5% Following Restructuring Plan, Berkshire Trims Apple Stake, and Latest NewsNYSE:GSKGSK plc
08/02/202413h00GlobeNewswire Inc.Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s DiseaseNYSE:GSKGSK plc
07/02/202422h01GlobeNewswire Inc.23andMe Reports Third Quarter Fiscal 2024 Financial ResultsNYSE:GSKGSK plc
07/02/202413h00GlobeNewswire Inc.FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)NYSE:GSKGSK plc
06/02/202413h00Business WireGSK’s RSV Vaccine, AREXVY, Accepted Under Priority Review in US for the Prevention of RSV Disease in Adults Aged 50-59 at Increased RiskNYSE:GSKGSK plc
01/02/202412h51Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
31/01/202419h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
31/01/202412h28IH Market NewsWalmart’s Stock Split, Elon Musk’s Billion-Dollar Package Revoked, and MoreNYSE:GSKGSK plc
30/01/202422h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GSKGSK plc
29/01/202412h33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
29/01/202412h26Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
24/01/202420h11Business WireElegen e GSK firmano un accordo di collaborazione e di licenza per sviluppare ulteriormente la tecnologia produttiva del DNA privo di cellule di ElegenNYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK

Kürzlich von Ihnen besucht

TG
432
Arbor Metals
AMEX
XLV
Health Care Select Sector
FX
EURGBP
Euro vs Sterling
COIN
SOLUSD
Solana
DBI
SDXP
SDAX
NYSE
DIS
Walt Disney
COIN
ETHUSD
Ethereum
PM
XAUUSD
Gold vs US Dollar
TG
DTE
Deutsche Telekom
AMEX
XLF
Financial Select Sector
DBI
MDAX
MDAX
NASDAQ
AAPL
Apple
DBI
DAX
DAX
TG
NOV
Novo Nordisk
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten